oxybutynin has been researched along with Cleft Spine in 11 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin is a good alternative to oxybutynin for management of neurogenic bladder, both as monotherapy and as an add-on therapy." | 2.82 | Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study. ( Bawa, M; Dash, V; Kanojia, RP; Mahajan, JK; Rao, KL; Samujh, R, 2016) |
| "Fifteen spina bifida patients, aged between 1 and 12 years, all on a regime of clean intermittent catheterisation (CIC) and oxybutynin since shortly after birth, underwent three consecutive urodynamic studies (UDS)." | 2.71 | Detrusor overactivity in spina bifida: how long does it need to be treated? ( Ab, E; de Jong, TP; Dik, P; Klijn, AJ; van Gool, JD, 2004) |
| " Data on tolerability, compliance, and adverse events (AEs) were also analyzed." | 1.40 | Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study. ( Baek, M; Han, SW; Kim, KR; Kim, KS; Lee, JH; Lee, YS; Park, K; Song, SH, 2014) |
| "Paraplegic spina bifida patients often suffer from disturbed sweat secretion in the paretic regions." | 1.38 | [Hyperthermia in spina bifida patients treated with oxybutynin]. ( Cremer, R, 2012) |
| "The study comprised 225 children with a neurogenic bladder from MMC who were evaluated with urodynamic testing and voiding cysto-urethrography to identify those at high risk of upper tract damage." | 1.31 | Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. ( D'Aleo, CM; Ferrara, P; Salvaggio, E; Salvatore, S; Tarquini, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, AS | 1 |
| Viseshsindh, W | 1 |
| Long, CJ | 1 |
| Frazier, JR | 1 |
| Moran, MH | 1 |
| Zderic, SA | 1 |
| Weiss, DA | 1 |
| Butler, L | 1 |
| Keys, C | 1 |
| Lam, JP | 1 |
| Veenboer, PW | 1 |
| Huisman, J | 1 |
| Chrzan, RJ | 1 |
| Kuijper, CF | 1 |
| Dik, P | 2 |
| de Kort, LM | 1 |
| de Jong, TP | 2 |
| Austin, PF | 1 |
| Lee, JH | 1 |
| Kim, KR | 1 |
| Lee, YS | 1 |
| Han, SW | 1 |
| Kim, KS | 1 |
| Song, SH | 1 |
| Baek, M | 1 |
| Park, K | 1 |
| Dash, V | 1 |
| Bawa, M | 1 |
| Mahajan, JK | 1 |
| Kanojia, RP | 1 |
| Samujh, R | 1 |
| Rao, KL | 1 |
| Wang, QW | 1 |
| Song, DK | 1 |
| Zhang, XP | 1 |
| Wu, YD | 1 |
| Zhang, RL | 1 |
| Wei, JX | 1 |
| Wen, JG | 1 |
| Cremer, R | 1 |
| Ab, E | 1 |
| Klijn, AJ | 1 |
| van Gool, JD | 1 |
| Buyse, G | 1 |
| Verpoorten, C | 1 |
| Vereecken, R | 1 |
| Casaer, P | 1 |
| Ferrara, P | 1 |
| D'Aleo, CM | 1 |
| Tarquini, E | 1 |
| Salvatore, S | 1 |
| Salvaggio, E | 1 |
2 trials available for oxybutynin and Cleft Spine
| Article | Year |
|---|---|
Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study.
Topics: Adolescent; Amines; Child; Child, Preschool; Cholinergic Antagonists; Cyclohexanecarboxylic Acids; F | 2016 |
Detrusor overactivity in spina bifida: how long does it need to be treated?
Topics: Child; Child, Preschool; Cholinergic Antagonists; Compliance; Female; Humans; Infant; Infant, Newbor | 2004 |
9 other studies available for oxybutynin and Cleft Spine
| Article | Year |
|---|---|
How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
Topics: Child; Follow-Up Studies; Humans; Infant; Mandelic Acids; Retrospective Studies; Spinal Dysraphism; | 2020 |
Bladder calculus formation on the tip of a migrated disused ventriculoperitoneal shunt.
Topics: Abnormalities, Multiple; Child; Cholinergic Antagonists; Combined Modality Therapy; Cystoscopy; Equi | 2013 |
Behavioral effects of long-term antimuscarinic use in patients with spinal dysraphism: a case control study.
Topics: Adolescent; Case-Control Studies; Child; Child Behavior; Child Behavior Disorders; Female; Humans; M | 2013 |
Symptoms and side effects: delicate balance in the management of patients with neurogenic bladder.
Topics: Child Behavior; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Spinal Dysraphism; Uri | 2013 |
Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism: a retrospective, multicenter, observational study.
Topics: Adolescent; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Male; | 2014 |
Urodynamic parameters development and complications of clean intermittent self-catheterization in Chinese schoolchildren with neurogenic underactive bladder.
Topics: Child; Child, Preschool; China; Female; Fever; Follow-Up Studies; Humans; Male; Mandelic Acids; Spin | 2011 |
[Hyperthermia in spina bifida patients treated with oxybutynin].
Topics: Child; Female; Fever; Humans; Male; Mandelic Acids; Parasympatholytics; Spinal Dysraphism; Treatment | 2012 |
Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
Topics: Administration, Intravesical; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Combined | 1995 |
Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
Topics: Administration, Intravesical; Administration, Oral; Child; Child, Preschool; Cholinergic Antagonists | 2001 |